Ossiam Incyte Corp Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Incyte Corp stock. As of the latest transaction made, Ossiam holds 9,702 shares of INCY stock, worth $746,762. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,702

Previous 71 13564.79%

Holding current value

$746,762

Previous $4,000 15925.0%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $552,145 - $660,782	9,631 Added 13564.79%	9,702 $641,000
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $1.23 Million - $1.54 Million	-24,084 Reduced 99.71%	71 $4,000
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $182,317 - $214,686	-3,224 Reduced 11.78%	24,155 $1.38 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $82,047 - $100,970	1,573 Added 6.1%	27,379 $1.72 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $26,689 - $30,459	-462 Reduced 1.76%	25,806 $1.49 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $1.29 Million - $1.6 Million	-21,132 Reduced 44.58%	26,268 $1.64 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $341,879 - $418,696	4,868 Added 11.45%	47,400 $3.43 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $975,520 - $1.22 Million	14,521 Added 51.84%	42,532 $3.42 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $437,648 - $547,953	6,613 Added 30.9%	28,011 $1.87 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $768,415 - $965,802	11,611 Added 118.64%	21,398 $1.63 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $588,238 - $710,216	8,910 Added 1015.96%	9,787 $777,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $4.28 Million - $5.01 Million	-67,624 Reduced 98.72%	877 $64,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $2.61 Million - $3.19 Million	37,962 Added 124.31%	68,501 $4.71 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $1.64 Million - $1.79 Million	20,496 Added 204.08%	30,539 $2.36 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $729,563 - $964,498	9,597 Added 2151.79%	10,043 $816,000
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $2.35 Million - $2.84 Million	-29,096 Reduced 98.49%	446 $39,000
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $719,011 - $927,099	-8,452 Reduced 22.25%	29,542 $2.65 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $1.01 Million - $1.48 Million	-13,557 Reduced 26.3%	37,994 $3.95 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $3.17 Million - $4.31 Million	50,161 Added 3608.71%	51,551 $3.78 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $116,571 - $152,769	-1,596 Reduced 53.45%	1,390 $121,000
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $157,946 - $187,661	2,169 Added 265.48%	2,986 $222,000
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $60,065 - $72,467	817 New	817 $69,000
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $27,966 - $38,794	-440 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $25,740 - $30,773	440 New	440 $28,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account